Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response-Reference-Cited by-同舟云学术

Interleukin- 28B: a prognostic marker in interferon based therapy of chronic HCV patients of the Pakistan with variable treatment response

Published:2015-07-14 Issue:9 Volume:123 Page:765-771
ISSN:0903-4641
Container-title:APMIS
language:en
Short-container-title:APMIS

Author:

Resham Saleha¹,Manzoor Sobia¹,Imran Muhammad¹,Saalim Muhammad¹,Naseem Sidrah¹,Azam Sikandar¹

Affiliation:

1. Atta-Ur-Rahman School of Applied Bio-Sciences; Department of Healthcare Biotechnology; National University of Sciences and Technology (NUST); Islamabad Pakistan

Publisher

Wiley

Subject

Microbiology (medical),General Medicine,Immunology and Allergy,Pathology and Forensic Medicine

Reference30 articles.

1. Course and outcome of hepatitis C;Hoofnagle;Hepatology,2002

2. Recent advances in the treatment of hepatitis C;Dhingra;Discov Med,2014

3. Hepatitis C virus infection: a review of the current and future aspects and concerns in Pakistan;Akbar;J Gen Mol Virol,2009

4. Genetic variant of IL28B rs12979860, as predictive marker of interferon-based therapy in Pakistani population;Imran;APMIS,2015

5. IL-28 and IL-29: newcomers to the interferon family;Uzé;Biochimie,2007

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The influence of interleukin 28B polymorphisms on the risk of hepatocellular carcinoma among patients with HBV or HCV infection;Medicine;2019-09

2. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges;Medicine;2016-12

3. IL28B rs12980275 and HLA rs4273729 genotypes as a powerful predictor factor for rapid, early, and sustained virologic response in patients with chronic hepatitis C;Archives of Virology;2016-10-06

4. Impact of host genetic polymorphisms on vaccine induced antibody response;Human Vaccines & Immunotherapeutics;2016-01-25

5. Predictive potential ofIL-28Bgenetic testing for interferon based hepatitis C virus therapy in Pakistan: Current scenario and future perspective;World Journal of Hepatology;2016